Abstract
Local recurrences after inadequate surgery are a major challenge in many cancers. Photochemical internalization (PCI) is a new technology to release endocytosed macromolecules into the cytosol by a photochemical rupture of the endocytic vesicles. A recent study on an invasive human fibrosarcoma xenograft HT1080 indicated low sensitivity of the tumour periphery to disulfonated aluminium phthalocyanine (AlPcS(2a))-based photochemical treatment. The main goal of the present study was to evaluate the sensitivity of the remaining tumour after marginal resection of the HT1080 tumour to the photochemical treatment alone and PCI of bleomycin. AlPcS(2a) and bleomycin was systemically administrated 48 h and 30 min, respectively, prior to surgery and immediately followed by intra-operative light exposure at 670 nm (15 J cm(-2)). PCI of bleomycin as an adjunct to surgery did significantly delay tumour growth in contrast to the photochemical treatment alone. The results indicate that PCI of bleomycin may be an efficient intra-operative technique to eradicate cancer cells in the wound bed after inadequate surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
